Initiation of warfarin therapy in elderly medical inpatients: A safe and accurate regimen - 21/08/11
, Isabelle Gouin, PhD a, Matthieu Debray, MD b, Christine Perret-Guillaume, MD c, Jacques Boddaert, MD d, Isabelle Mahé, MD e, Valérie Donval, MD f, Marie-Laure Seux, MD g, Marjolaine Romain-Pilotaz, MD h, Mathilde Gisselbrecht, MD i, Marc Verny, MD, PhD d, Eric Pautas, MD jRésumé |
Purpose |
Elderly patients are at high risk of over-anticoagulation when treated with warfarin, especially during treatment induction. We developed a simple low-dose regimen for starting warfarin therapy in elderly inpatients. The daily maintenance dosage is predicted from the international normalized ratio (INR) measured the day after the third daily intake of a 4-mg dose. We conducted a prospective multicenter study to evaluate the accuracy and safety of this regimen.
Methods |
We studied 106 elderly (age ≥70 years) inpatients (mean [± SD] age, 85 ± 6 years; range, 71 to 97 years) who had a target INR of 2.0 to 3.0. Accuracy in predicting the daily maintenance dose from INR value on day 3 was evaluated.
Results |
The predicted daily maintenance warfarin dose (3.1 ± 1.6 mg/d) correlated closely with the actual maintenance dose (3.2 ± 1.7 mg/d; R2 = 0.84). The predicted dose was equal to the actual dose in 77 patients (73%; 95% confidence interval [CI]: 64% to 81%) and within 1 mg in 101 patients (95%; 95% CI: 91% to 99%). The mean time needed to achieve a therapeutic INR was 6.7 ± 3.3 days (median, 6.0 days); the mean time needed to achieve the maintenance dose was 9.2 ± 4.5 days (median, 7.0 days). None of the patients had an INR >4.0 during this period. One fatal bleeding event was recorded in a patient with an INR in the therapeutic range.
Conclusion |
Our warfarin induction regimen was simple, safe, and accurate in predicting the daily maintenance warfarin dose in elderly hospitalized patients.
Le texte complet de cet article est disponible en PDF.Keywords : Warfarin, INR, Regimen, Elderly
Plan
Vol 118 - N° 2
P. 137-142 - février 2005 Retour au numéro
Article précédent
- Triiodothyronine levels for risk stratification of patients with chronic heart failure
- Alessandro Pingitore, Patrizia Landi, Maria Chiara Taddei, Andrea Ripoli, Antonio L’Abbate, Giorgio Iervasi
- Tailoring warfarin induction doses to reflect individual and disease-specific factors
- Walter Ageno, Alessandro Squizzato, Francesco Dentali, Mark Crowther
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?